Search Within

Tomas Kirchhoff

Formats
  1. Journal Article (42)
  2. Meeting Abstract (11)
Groups
  1. Clinical Genetics Service (52)
  2. Department of Medicine (52)
  3. GSK Faculty (52)
  4. Population Sciences Research Program (52)
  5. Solid Tumor Oncology Division (52)
  6. Survivorship Research (52)

More Groups

People
  1. Kenneth Offit (52)
  2. Vijai Joseph (14)
  3. Mark Robson (12)
  4. Robert Klein (11)
  5. Ana Virginia Dutra-Clarke (10)
  6. Khedoudja Nafa (9)

More People

Years
  1. 2013 (3)
  2. 2012 (2)
  3. 2011 (8)
  4. 2010 (11)
  5. 2009 (7)
  6. 2008 (7)

More Years

Publications
  1. Cancer Research (8)
  2. Journal of Clinical Oncology (5)
  3. Clinical Cancer Research (3)
  4. Human Molecular Genetics (3)
  5. Proceedings of the National Academy of Sciences of the United States of America (3)
  6. American Journal of Human Genetics (2)

More Publications

Publishers
  1. American Association for Cancer Research (13)
  2. American Society of Clinical Oncology (5)
  3. Nature Publishing Group (5)
  4. Oxford University Press (5)
  5. Springer (5)
  6. Public Library of Science (4)

More Publishers

Results (53)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Breast cancer risk prediction using the novel germ-line signatures in epigenome regulatory pathways
    Meeting Abstract

    Adaniel, C.; Rendleman, J.; Smith, J. A.; Klein, R. J.; Schnabel, F. R.; Shao, Y. Z.; Offit, K.; Kirchhoff, T.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Assessment of SLX4 Mutations in Hereditary Breast Cancers
    Journal Article

    Shah, S.; Kim, Y.; Ostrovnaya, I.; Murali, R.; Schrader, K. A.; Lach, F. P.; Sarrel, K.; Rau-Murthy, R.; Hansen, N.; Zhang, L.; more...
    PLoS ONE (2013)

    Fulltext@MSK | Save
  • Susceptibility Loci Associated with Specific and Shared Subtypes of Lymphoid Malignancies
    Journal Article

    Vijai, J.; Kirchhoff, T.; Schrader, K. A.; Brown, J.; Dutra Clarke, A. V.; Manschreck, C.; Hansen, N.; Rau-Murthy, R.; Sarrel, K.; Przybylo, J.; more...
    PLoS Genetics (2013)

    Fulltext@MSK | Save
  • Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry
    Journal Article

    Wang, Z.; Parikh, H.; Jia, J.; Myers, T.; Yeager, M.; Jacobs, K. B.; Hutchinson, A.; Burdett, L.; Ghosh, A.; Thun, M. J.; more...
    Human Genetics (2012)

    Fulltext@MSK | Save
  • Breast cancer risk and 6q22.33: Combined results from breast cancer association consortium and consortium of investigators on modifiers of BRCA1/2
    Journal Article

    Kirchhoff, T.; Offit, K.; Gaudet, M. M.; Pharoah, P. D. P.; Easton, D. F.; Antoniou, A. C.; McGuffog, L.; Humphreys, M. K.; Dunning, A. M.; Bojesen, S. E.; more...
    PLoS ONE (2012)

    Fulltext@MSK | Save
  • Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma
    Meeting Abstract

    Onel, K.; Best, T.; Skol, A. D.; Li, D. L.; Kirchhoff, T.; Yasui, Y.; Bhatia, S.; Strong, L. C.; Domchek, S. M.; Nathanson, K. L.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers
    Journal Article

    Im, K. M.; Kirchhoff, T.; Wang, X. S.; Green, T.; Chow, C. Y.; Vijai, J.; Korn, J.; Gaudet, M. M.; Fredericksen, Z.; Pankratz, V. S.; more...
    Human Genetics (2011)

    Fulltext@MSK | Save
  • Genetic architecture of prostate cancer in the Ashkenazi Jewish population
    Journal Article

    Vijai, J.; Kirchhoff, T.; Gallagher, D.; Hamel, N.; Guha, S.; Darvasi, A.; Lencz, T.; Foulkes, W. D.; Offit, K.; Klein, R. J.
    British Journal of Cancer (2011)

    Fulltext@MSK | Save
  • Relative contributions of BRCA1 and BRCA2 mutations to "triple- negative" breast cancer in Ashkenazi Women
    Journal Article

    Comen, E.; Davids, M.; Kirchhoff, T.; Hudis, C.; Offit, K.; Robson, M.
    Breast Cancer Research and Treatment (2011)

    Fulltext@MSK | Save
  • Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma
    Journal Article

    Best, T.; Li, D.; Skol, A. D.; Kirchhoff, T.; Jackson, S. A.; Yasui, Y.; Bhatia, S.; Strong, L. C.; Domchek, S. M.; Nathanson, K. L.; more...
    Nature Medicine (2011)

    Fulltext@MSK | Save